Victoria Margulets

St. Boniface Hospital Albrechtsen Research Centre
Winnipeg, MB R2H2H6, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

IKKβ stabilizes Mitofusin 2 and suppresses doxorubicin cardiomyopathy.

IKKβ stabilizes Mitofusin 2 and suppresses doxorubicin cardiomyopathy.

Journal: Cardiovascular research

Published: December 29, 2022

Ellagic acid inhibits mitochondrial fission protein Drp-1 and cell proliferation in cancer.

Ellagic acid inhibits mitochondrial fission protein Drp-1 and cell proliferation in cancer.

Journal: Molecular and cellular biochemistry

Published: September 21, 2022

Proteasomal Degradation of TRAF2 Mediates Mitochondrial Dysfunction in Doxorubicin-Cardiomyopathy.

Proteasomal Degradation of TRAF2 Mediates Mitochondrial Dysfunction in Doxorubicin-Cardiomyopathy.

Journal: Circulation

Published: August 19, 2022

Mitochondrial autophagy and cell survival is regulated by the circadian Clock gene in cardiac myocytes during ischemic stress.

Mitochondrial autophagy and cell survival is regulated by the circadian Clock gene in cardiac myocytes during ischemic stress.

Journal: Autophagy

Published: June 04, 2021

Modulating mitofusins to control mitochondrial function and signaling.

Modulating mitofusins to control mitochondrial function and signaling.

Journal: Nature communications

Published: April 29, 2021

A small-molecule allosteric inhibitor of BAX protects against doxorubicin-induced cardiomyopathy.

A small-molecule allosteric inhibitor of BAX protects against doxorubicin-induced cardiomyopathy.

Journal: Nature cancer

Published: August 11, 2020

Impaired NF-κB signalling underlies cyclophilin D-mediated mitochondrial permeability transition pore opening in doxorubicin cardiomyopathy.

Impaired NF-κB signalling underlies cyclophilin D-mediated mitochondrial permeability transition pore opening in doxorubicin cardiomyopathy.

Journal: Cardiovascular research

Published: June 07, 2019

Reduction of myocardial ischaemia-reperfusion injury by inactivating oxidized phospholipids.

Reduction of myocardial ischaemia-reperfusion injury by inactivating oxidized phospholipids.

Journal: Cardiovascular research

Published: March 05, 2018

Ellagic acid antagonizes Bnip3-mediated mitochondrial injury and necrotic cell death of cardiac myocytes.

Ellagic acid antagonizes Bnip3-mediated mitochondrial injury and necrotic cell death of cardiac myocytes.

Journal: Free radical biology & medicine

Published: April 05, 2017

PDK2-mediated alternative splicing switches Bnip3 from cell death to cell survival.

PDK2-mediated alternative splicing switches Bnip3 from cell death to cell survival.

Journal: The Journal of cell biology

Published: September 30, 2015

Bcl-2/adenovirus E1B 19-kDa interacting protein (BNip3) has a key role in the mitochondrial dysfunction induced by mutant huntingtin.

Bcl-2/adenovirus E1B 19-kDa interacting protein (BNip3) has a key role in the mitochondrial dysfunction induced by mutant huntingtin.

Journal: Human molecular genetics

Published: May 28, 2015

Bnip3 mediates doxorubicin-induced cardiac myocyte necrosis and mortality through changes in mitochondrial signaling.

Bnip3 mediates doxorubicin-induced cardiac myocyte necrosis and mortality through changes in mitochondrial signaling.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: December 10, 2014

Showing 1-12 of 14

Last Updated: 09/26/2026